Rankings
▼
Calendar
CGEM Q4 2019 Earnings — Cullinan Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
CGEM
Cullinan Therapeutics, Inc.
$841M
Q4 2019 Earnings
Healthcare
Medical - Pharmaceuticals
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$5M
Net Income
-$5M
EPS (Diluted)
$-0.24
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$5M
Free Cash Flow
-$5M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$100M
Total Liabilities
$140M
Stockholders' Equity
-$41M
Cash & Equivalents
$63M
← FY 2019
All Quarters
Q1 2020 →
